Medicare Proposes Changes To ASP Reporting Requirements For Part B Drugs
Executive Summary
CMS is proposing to expand average sales price (ASP) data reporting requirements for manufacturers to include wholesale acquisition costs of Medicare Part B drugs
You may also be interested in...
Medicaid Would Pay ASP+6% To Pharmacies Under White House Bill
The Centers for Medicare & Medicaid Services is forging ahead with its proposal to set pharmacy reimbursement levels under Medicaid at average sales price plus 6% for drugs, despite opposition from industry groups and state governors
“Average Sales Price” Rule Issued; Definition Mirrors Medicare Rx Law
CMS' definition of "average sales price" for drugs closely follows the language in the Medicare Rx law
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011